Generic Name: antihemophilic factor / von willebrand factor
Applies to antihemophilic factor / von willebrand factor: intravenous powder for solution
As well as its needed effects, antihemophilic factor / von willebrand factor may cause unwanted side effects that require medical attention. 

If any of the following side effects occur while taking antihemophilic factor / von willebrand factor, check with your doctor or nurse immediately:


Applies to antihemophilic factor / von willebrand factor: intravenous powder for injection
The most serious side effects were anaphylaxis/hypersensitivity reactions.[Ref]
Common (1% to 10%): Allergy, infection, hypersensitivityUncommon (0.1% to 1%): Factor VIII inhibitionVery rare (less than 0.01%): Von Willebrand factor inhibition, anaphylactic shockFrequency not reported: Allergic-anaphylactic reactions, sepsis[Ref]
Very common (10% or more): Pain (up to 17.5%)Common (1% to 10%): Fever, surgery, facial edema, chest pain, peripheral edema, rigorsFrequency not reported: Chills, pseudothrombocytopenia, postoperative painPostmarketing reports: Fatigue, malaise[Ref]
Very common (10% or more): Nausea (up to 23.8%), constipation (11.1%)Common (1% to 10%): Gastrointestinal bleeding, abdominal pain, vomitingFrequency not reported: Postoperative nausea[Ref]
Common (1% to 10%): Groin bleed, ear bleed, shoulder bleed, anemia/hemoglobin decreased, thromboembolic eventFrequency not reported: Hemorrhage, hematocrit decreased, postoperative hemorrhage, postoperative wound bleedingPostmarketing reports: Hemolysis[Ref]
Common (1% to 10%): Cerebral hemorrhage/subdural hematoma, dizziness, headache, dysgeusia, somnolenceFrequency not reported: Headache, paresthesia, drowsiness[Ref]
Common (1% to 10%): Epistaxis, hemoptysis, pulmonary embolus, sore throatFrequency not reported: Respiratory distressPostmarketing reports: Dyspnea, cough, sneezing, throat irritation[Ref]
Common (1% to 10%): Sweating increased, pruritus, rash, urticaria[Ref]
Common (1% to 10%): Menorrhagia, hematuria, urinary retention, urinary tract infection[Ref]
Common (1% to 10%): ALT increased, liver function test abnormal[Ref]
Common (1% to 10%): Back pain, muscle and joint stiffnessFrequency not reported: Extremity painPostmarketing reports: Joint pain[Ref]
Common (1% to 10%): ThrombophlebitisFrequency not reported: Orthostatic hypotension, phlebitis, vasodilation, bradycardia, palpitations[Ref]
Common (1% to 10%): Infusion site erythema or rash or painFrequency not reported: Injection site bleedingPostmarketing reports: Infusion site pain[Ref]
Common (1% to 10%): Insomnia[Ref]
Frequency not reported: Blurred vision[Ref]
Frequency not reported: Pyelonephritis[Ref]
Postmarketing reports: Hypervolemia[Ref]
1. Cerner Multum,  Inc. "Australian Product Information." O 0
2. "Product Information. Alphanate (antihemophilic factor-von Willebrand factor)." Alpha Therapeutic Corporation, Los Angeles, CA. 
3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0
4. "Product Information. Wilate (antihemophilic factor-von Willebrand factor)." Octapharma USA, Centreville, VA. 
5. "Product Information. Humate-P (antihemophilic factor-von Willebrand factor)." CSL Behring, King of Prussia, PA. 
It is possible that some side effects of Wilate may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.

Difficulty with breathing or swallowing
dizziness
fast heartbeat
fever
hives or welts
itching
nausea
reddening of the skin, especially around the ears
shortness of breath
skin rash
swelling of the face, throat, or tongue
unusual tiredness or weakness


Cough
tightness in the chest
vomiting
wheezing

